News Focus
News Focus
icon url

DewDiligence

03/20/17 11:48 AM

#210004 RE: DewDiligence #202380

Uh oh—ABT’s ABSORB stent showing higher MACE rate than Xience in FDA post-marketing analysis:

https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm547256.htm